Regenxbio Inc (RGNX)
9.59
+0.41
(+4.47%)
USD |
NASDAQ |
Nov 22, 16:00
9.60
+0.01
(+0.10%)
After-Hours: 20:00
Regenxbio Price: 9.59 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 22, 2024 | 9.15 | 9.82 | 9.00 | 9.59 | 683602.0 |
| Nov 21, 2024 | 9.38 | 9.70 | 9.08 | 9.18 | 699728.0 |
| Nov 20, 2024 | 9.56 | 9.80 | 9.01 | 9.63 | 806144.0 |
| Nov 19, 2024 | 9.92 | 9.94 | 8.865 | 9.56 | 2.030M |
| Nov 18, 2024 | 11.11 | 11.38 | 9.93 | 10.15 | 3.074M |
| Nov 15, 2024 | 11.56 | 11.63 | 9.58 | 9.63 | 1.285M |
| Nov 14, 2024 | 10.73 | 12.11 | 10.73 | 11.14 | 1.249M |
| Nov 13, 2024 | 10.70 | 10.73 | 10.24 | 10.67 | 572158.0 |
| Nov 12, 2024 | 11.30 | 11.41 | 10.49 | 10.49 | 674770.0 |
| Nov 11, 2024 | 11.29 | 12.22 | 11.29 | 11.56 | 724338.0 |
| Nov 08, 2024 | 11.22 | 11.70 | 10.76 | 11.16 | 1.085M |
| Nov 07, 2024 | 10.20 | 11.62 | 10.00 | 11.19 | 1.737M |
| Nov 06, 2024 | 9.27 | 9.45 | 8.95 | 9.43 | 669004.0 |
| Nov 05, 2024 | 8.70 | 8.97 | 8.58 | 8.92 | 364491.0 |
| Nov 04, 2024 | 8.84 | 8.89 | 8.55 | 8.76 | 369384.0 |
| Nov 01, 2024 | 8.72 | 8.88 | 8.535 | 8.79 | 476799.0 |
| Oct 31, 2024 | 8.80 | 8.985 | 8.565 | 8.59 | 502230.0 |
| Oct 30, 2024 | 8.93 | 9.27 | 8.815 | 8.84 | 395989.0 |
| Oct 29, 2024 | 9.36 | 9.46 | 8.90 | 9.06 | 427260.0 |
| Oct 28, 2024 | 9.50 | 9.745 | 9.26 | 9.38 | 437604.0 |
| Oct 25, 2024 | 9.67 | 9.84 | 9.305 | 9.35 | 394841.0 |
| Oct 24, 2024 | 9.87 | 9.87 | 9.40 | 9.58 | 369899.0 |
| Oct 23, 2024 | 9.54 | 9.81 | 9.45 | 9.74 | 490296.0 |
| Oct 22, 2024 | 10.27 | 10.32 | 9.41 | 9.59 | 486799.0 |
| Oct 21, 2024 | 10.99 | 11.23 | 10.28 | 10.37 | 765207.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
8.59
Minimum
Oct 31 2024
54.20
Maximum
Feb 13 2020
27.26
Average
26.94
Median
Price Benchmarks
| Catalyst Pharmaceuticals Inc | 21.48 |
| EyePoint Pharmaceuticals Inc | 8.95 |
| Cassava Sciences Inc | 26.48 |
| Vertex Pharmaceuticals Inc | 450.97 |
| Sarepta Therapeutics Inc | 114.23 |
Price Related Metrics
| PS Ratio | 5.434 |
| Price to Book Value | 1.576 |
| Earnings Yield | -52.35% |
| Market Cap | 475.14M |